Primary record
EXEL 2880; GSK 1363089; GSK 1363089G; N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; XL 880
- 库存
- 9,583 克
- 纯度
- 98.7 %
- CAS
- 849217-64-7
化合物标识与属性
- CAS
- 849217-64-7
- PubChem CID
- 42642645
- SMILES
- COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
- Canonical SMILES
- COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1
名称与同义词
- Foretinib
- 849217-64-7
- foretinibum
- XL880
- GSK1363089
- Foretinib (GSK1363089)
- MET inhibitors
- EXEL-2880
- GSK089
- Foretinib(XL880)
- XL-880
- XL880 cpd
- xl-880, Foretinib
- Foretinib(XL880)?
- Foretinib?XL-880?
- FORETINIB [INN]
- GSK 1363089
- Foretinib [USAN:INN]
- XL 880
- EXEL 2880
- FORETINIB [USAN]
- Foretinib (XL-880)
- GSK-089
- RefChem:599622
- 81FH7VK1C4
- MFCD16038048
- D0D1GF
- GSK-1363089
- FORETINIB [WHO-DD]
- GSK1363089G
- UNII-81FH7VK1C4
- cc-541
- MLS006010302
- SCHEMBL371804
- C34H34F2N4O6
- DTXSID20918193
- GSK-1363089G
- EXEL-288
- Foretinib - GSK1363089
- GTPL5679
- orb1304524
- QCR-49
- CHEMBL1230609
- SCHEMBL29358674
- SCHEMBL30498609
- CHEBI:91418
- AOB6031
- EX-A050
- GSK 089
- SYN1129
- CXQHYVUVSFXTMY-UHFFFAOYSA-N
- BCPP000236
- DTXCID501347147
- GLXC-05712
- HMS3295K13
- HMS3654G04
- BCP02231
- ABP000883
- BDBM50399540
- EBC-11398
- GSK 1363089G
- NSC755775
- NSC800101
- s1111
- ZINC43204048
- Foretinib,XL880, GSK1363089
- AKOS015904319
- BCP9000675
- CCG-270292
- CS-0153
- DB12307
- FF42412
- Foretinib?GSK1363089??XL880?
- NSC-755775
- NSC-800101
- PB27007
- RL05228
- SB20469
- SDCCGSBI-0654343.P001
- Foretinib (GSK1363089, XL880)
- MET/VEGFR-2 inhibitor GSK1363089
- NCGC00263104-01
- NCGC00263104-10
- AC-25081
- AS-16268
- BC622993
- CID:42642645
- HY-10338
- SMR003599144
- SY269694
- SID:137275745
- AB0008088
- N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- A2974
- NS00072564
- SW219390-1
- W8766
- EC-000.2326
- J3.100.657K
- A10998
- A25642
- Q-4937
- S-7795
- XL880, GSK1363089G, Exel 2880
- Z-3260
- EXEL-2880/XL880/GSK1363089/Foretinib
- C544831
- Multitargeted Tyrosine Kinase Inhibitor GSK1363089
- Q5469311
- BRD-K03449891-001-01-1
- BRD-K03449891-001-08-6
- I14-17014
- 937176-80-2
- GSK089, EXEL-2880, 849217-64-7
- B2693-152657
- 1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- GSK1363089, GSK089, foretinib, EXEL-2880, XL880
- 88Z
- N'1-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(3-Fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(3-Fluoro-4-{[6-Methoxy-7-(3-Morpholin-4-Ylpropoxy)quinolin-4-Yl]oxy}phenyl)-N'-(4-Fluorophenyl)cyclopropane-1,1-Dicarboxamide
- N-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1,1-CYCLOPROPANEDICARBOXAMIDE, N-(3-FLUORO-4-((6-METHOXY-7-(3-(4- MORPHOLINYL)PROPOXY)-4-QUINOLINYL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)-
- 1,1-Cyclopropanedicarboxamide, N-(3-fluoro-4-((6-methoxy-7-(3-(4-morpholinyl)propoxy)-4-quinolinyl)oxy)phenyl)-N'-(4-fluorophenyl)-
- 1-N'-(3-fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1-N'-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1-N-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- EXEL 2880; GSK 1363089; GSK 1363089G; N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; XL 880
- N'1-(3-fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- n-(3-fluoro-4-((6-methoxy-7-(3-(4-morpholinyl)propoxy)-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- N-(3-FLUORO-4-((6-METHOXY-7-(3-(MORPHOLIN-4-YL)PROPOXY)QUINOLIN-4-YL)OXY) PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE
- N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)-oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(3-fluoro-4-(6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(4-(7-(3-MORPHOLINOPROPOXY)-6-METHOXYQUINOLIN-4-YLOXY)-3-FLUOROPHENYL)-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE
- N-(4-Fluorophenyl)-N -[3-fluoro-4-[6-methoxy-7-(3-morpholinopropoxy)-4-quinolyloxy]phenyl]cyclopropane-1,1-dicarboxamide
- N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin 4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl]oxy)phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[3-Fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-1-[(4-fluorophenyl)carbamoyl]cyclopropane-1-carboximidic acid
- N-[3-Fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl]oxy]phenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N1'-[3-fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide